價格 | 詢價 |
包裝 | 50μg |
最小起訂量 | 50μg |
發(fā)貨地 | 上海 |
更新日期 | 2025-02-18 |
中文名稱:Recombinant Human Galectin-3 | 英文名稱:Recombinant Human Galectin-3 |
有效期: 一年 | 產品類別: 重組蛋白 其他重組蛋白 |
產品編號 | 產品名稱 | 產品包裝 | 產品價格 |
P7302-50μg | Recombinant Human Galectin-3 | 50μg | 1152.00元 |
Species | Gene ID | Accession | Source | Length | MW | Tag |
Human | 3958 | P17931 | E. coli | 249aa | 26kDa | - |
About this Antibody | |
Name | Recombinant Human Galectin-3 (Recombinant Human Galectin-3; rHuGalectin-3);重組人半乳糖凝集素3 |
Synonyms | AGE-R3; CBP35; GAL3; L29; LGALS3; Mac-2; Carbohydrate-binding protein 35; CBP 35,35 kDa lectin; Gal-3; galactin-3; Galactose-specific lectin 3; Galactoside-binding protein; GALBPCBP35; galectin-3; GALIG; IgE-binding protein; L31; L-31; Laminin-binding protein; Lectin L-29; lectin, galactoside-binding, soluble, 3; LGALS2; MAC-2; Mac-2 antigen; MAC2GAL3 |
Purity | >98% by SDS-PAGE and HPLC analyses. |
Biological Activity | Fully biologically active when compared to standard. The ED50 as determined by its ability to agglutinate human red blood cells is less than 10μg/ml. |
Physical Appearance | Sterile Filtered White lyophilized (freeze-dried) powder. |
Formulation | Lyophilized from a 0.2μm filtered solution in 1X PBS, pH7.4, 3mM DTT. |
Endotoxin | Less than 0.1EU/μg of rHuGalectin-3 as determined by LAL method. |
Reconstitution | We recommend that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. Reconstitute in sterile distilled water or aqueous buffer containing 0.1% BSA to a concentration of 0.1-1.0mg/ml. Stock solutions should be apportioned into working aliquots and stored at ≤-20℃. Further dilutions should be made in appropriate buffered solutions. |
Category | Others |
Background | Human Galectin-3 also named AGE-R3, CBP35, GAL3, L29, LGALS3, Mac-2, is belonging to the galectins family and it is encoded by a single gene, LGALS3, located on chromosome 14, locus q21–q22. It is expressed in the nucleus, cytoplasm, mitochondrion, cell surface, and extracellular space. Galectin-3 is approximately 30kDa and, like all galectins, contains a carbohydrate-recognition-binding domain (CRD) of about 130 amino acids that enable the specific binding of β-galactosides. Given Galectin-3's broad biological functionality, it has been demonstrated to be involved in cancer, inflammation and fibrosis, heart disease, and stroke. Studies have also shown that the expression of galectin-3 is implicated in a variety of processes associated with heart failure, including myofibroblast proliferation, fibrogenesis, tissue repair, inflammation, and Ventricular remodeling. Human Galectin-3 shares 79% amino acid sequence identity with rat and mouse Galectin-3, respectively. |
Amino Acid Sequence | ADNFSLHDAL SGSGNPNPQG WPGAWGNQPA GAGGYPGASY PGAYPGQAPP GAYPGQAPPG AYPGAPGAYP GAPAPGVYPG PPSGPGAYPS SGQPSATGAY PATGPYGAPA GPLIVPYNLP LPGGVVPRML ITILGTVKPN ANRIALDFQR GNDVAFHFNP RFNENNRRVI VCNTKLDNNW GREERQSVFP FESGKPFKIQ VLVEPDHFKV AVNDAHLLQY NHRVKKLNEI SKLGISGDID LTSASYTMI |
包裝清單:
產品編號 | 產品名稱 | 包裝 |
P7302-10μg | Recombinant Human Galectin-3 | 10μg |
P7302-50μg | Recombinant Human Galectin-3 | 50μg |
P7302-100μg | Recombinant Human Galectin-3 | 100μg |
P7302-1mg | Recombinant Human Galectin-3 | 1mg |
- | 說明書 | 1份 |
保存條件:
???????-20℃或更低溫度保存,至少一年有效。由于蛋白的每次凍融均會引起部分失活,所以首次配制成相應濃度的儲存液后(請根據產品簡介中Reconstitution一欄的信息配制儲存液),須分裝后-20℃或更低溫度凍存,以避免反復凍融。
注意事項:
???????由于有些塑料管壁對某些蛋白有較強的吸附作用,溶液中的蛋白很容易粘附在管壁上,并且粘附后的蛋白很難與管壁分離。而載體蛋白(Carrier protein,如0.1% BSA等)的主要作用是預先封閉塑料管壁上的蛋白結合位點,使細胞因子或重組蛋白不會粘附于管壁。所以一定要使用產品簡介中Reconstitution一欄的信息配制儲存液。
???????本產品僅限于專業(yè)人員的科學研究用,不得用于臨床診斷或治療,不得用于食品或藥品,不得存放于普通住宅內。
???????為了您的安全和健康,請穿實驗服并戴一次性手套操作。
成立日期 | 2007-07-19 (18年) | 注冊資本 | 1000.000000萬人民幣 |
員工人數 | 500人以上 | 年營業(yè)額 | ¥ 500萬-1000萬 |
主營行業(yè) | 生化試劑,核苷,核苷酸,寡核苷酸,抗體,蛋白組學,生物活性小分子 | 經營模式 | 試劑 |
產品名稱 | 價格 | 公司名稱 | 報價日期 | |
---|---|---|---|---|
¥646 |
VIP6年
|
上??道噬锟萍加邢薰?/div>
|
2025-03-05 | |
詢價 |
VIP4年
|
武漢艾美捷科技有限公司
|
2025-02-05 | |
¥2800.00 |
VIP9年
|
北京索萊寶科技有限公司
|
2025-03-05 | |
¥646 |
VIP6年
|
上??道噬锟萍加邢薰?/div>
|
2025-03-05 | |
¥1950 |
VIP3年
|
上海滬震實業(yè)有限公司
|
2025-03-05 |